Financials QHSLab, Inc.

Equities

USAQ

US90350R1077

Healthcare Facilities & Services

Market Closed - OTC Markets 07:17:12 10/06/2024 pm IST 5-day change 1st Jan Change
0.25 USD +0.04% Intraday chart for QHSLab, Inc. +49.34% +177.78%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2.154 0.172 3.039 6.392 1.528 0.8762
Enterprise Value (EV) 1 2.593 0.4901 3.575 7.404 3.028 2.606
P/E ratio -55.8 x -1.56 x -8.77 x -7.45 x -1.48 x -1.81 x
Yield - - - - - -
Capitalization / Revenue - - 2,43,99,721 x 45,19,126 x 12,28,893 x 6,21,858 x
EV / Revenue - - 2,87,09,143 x 52,34,663 x 24,35,468 x 18,49,662 x
EV / EBITDA - - - -1,58,81,564 x -61,98,961 x -1,55,08,548 x
EV / FCF - -27,18,988 x -3,41,97,454 x -2,78,50,670 x -25,71,32,909 x 14,63,06,911 x
FCF Yield - -0% -0% -0% -0% 0%
Price to Book -4.04 x -0.64 x -4.99 x 7.76 x 20.1 x -2.33 x
Nbr of stocks (in thousands) 3,590 3,590 6,563 8,756 9,316 9,736
Reference price 2 0.6000 0.0479 0.4630 0.7300 0.1640 0.0900
Announcement Date 28/03/19 21/02/20 11/03/21 01/04/22 29/03/23 27/03/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - - 0.1245 1.414 1.243 1.409
EBITDA - - - -0.4662 -0.4884 -0.168
EBIT 1 -0.0274 -0.1541 -0.2751 -0.5023 -0.5605 -0.2402
Operating Margin - - -220.91% -35.51% -45.09% -17.04%
Earnings before Tax (EBT) 1 -0.0386 -0.1665 -0.3274 -0.7702 -0.996 -0.4684
Net income 1 -0.0386 -0.1665 -0.3274 -0.7702 -0.996 -0.4684
Net margin - - -262.89% -54.45% -80.12% -33.24%
EPS 2 -0.0108 -0.0308 -0.0528 -0.0980 -0.1107 -0.0497
Free Cash Flow - -0.1802 -0.1045 -0.2658 -0.0118 0.0178
FCF margin - - -83.95% -18.8% -0.95% 1.26%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 28/03/19 21/02/20 11/03/21 01/04/22 29/03/23 27/03/24
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales 1 0.33 0.3553 0.3508 0.2693 0.2677 0.3528
EBITDA - - - - - -
EBIT 1 -0.0632 -0.0141 -0.0737 -0.2034 -0.1277 -0.1027
Operating Margin -19.14% -3.97% -21% -75.53% -47.69% -29.12%
Earnings before Tax (EBT) 1 -0.2704 -0.1903 -0.2794 -0.3101 -0.2162 -0.1926
Net income 1 -0.2704 -0.1903 -0.2794 -0.3101 -0.2162 -0.1926
Net margin -81.94% -53.56% -79.64% -115.15% -80.76% -54.58%
EPS 2 -0.0300 -0.0200 -0.0300 -0.0300 -0.0200 -0.0200
Dividend per Share - - - - - -
Announcement Date 01/04/22 16/05/22 15/08/22 14/11/22 29/03/23 12/05/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 0.44 0.32 0.54 1.01 1.5 1.73
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) - - - -2.171 x -3.071 x -10.29 x
Free Cash Flow - -0.18 -0.1 -0.27 -0.01 0.02
ROE (net income / shareholders' equity) 7.51% 34.6% 63.1% -714% -221% 313%
ROA (Net income/ Total Assets) - -686% -106% -25% -16.8% -8.25%
Assets 1 - 0.0243 0.3087 3.075 5.922 5.677
Book Value Per Share 2 -0.1500 -0.0700 -0.0900 0.0900 0.0100 -0.0400
Cash Flow per Share - 0 0.0100 0.0300 0.0200 0.0100
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 28/03/19 21/02/20 11/03/21 01/04/22 29/03/23 27/03/24
1USD in Million2USD
Estimates
  1. Stock Market
  2. Equities
  3. USAQ Stock
  4. Financials QHSLab, Inc.